Table 1.
Author | Year | Country | Analytic Sample | Baseline Age | % Female | % White | Follow-up (Years)a | In Meta-analysis? | Depression assessed via interview? | Biomarkers Assessed (Method) | CRP>10b? | Covariates? | Exclusion Criteriac | Quality |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Khandaker et al. | 2014 | UK | 4415 | 9 | 48.0 | 98 | 8.8 | Yes | No | Blood | No | a , b, c, d, e, f, s | d | 7 |
Adriaensen et al. | 2014 | Belgium | 303 | 84.3 | 62.7 | nr | 1.7 | No | No | Blood | No | a, b, e, f, n, o, s | a | 5 |
Deverts et al. | 2010 | USA | 2544 | 40.2 | 55.0 | 58.2 | 5.0 | Yes | No | Blood | Yes | a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, s | d | 6 |
Elovainio et al. | 2006 | Finland | 1201 | 22.5 | 59.4 | nr | 9.0 | Yes | No | Blood | No | a, b, d, e, h, i, j, k, l, s | a | 5 |
Simanek et al. | 2014 | USA | 263 | 54 | 57.4 | 13.7 | 1.0 | Yes | No | Blood | No | h, i, o, p | c | 5 |
Au et al. | 2015 | UK | 3397 | 64.6 | 56 | 99 | 4.0 | Yes | No | Blood | No | a, b, d, e, f, h, j, k, l, n, o, s | none | 5 |
Copeland et al. | 2012 | USA | 1334 | 14.2 | 49 | 89.7 | 1.0 | Yes | Yes | Finger | Yes | a, b, c, d, e, f, g, h, i, o, s | none | 5 |
Brown et al. | 2016 | USA | 3075 | 73.6 | 52 | 58.3 | 10.0 | No | No | Blood | No CRP | a, b, e, n, o, q | d | 4 |
Hiles et al. | 2015 | Australia | 1410 | 65.6 | 50 | nr | 4.5 | Yes | No | Blood | Yes | a, b, e, f, h, i, j, n, s | a, b, d | 5 |
Milaneschi et al. | 2009 | Italy | 550 | 75 | 56 | nr | 3.0 | No | No | Blood | No | c | 6 | |
de Mello Franco et al. | 2017 | Brazil | 1508 | 41.31 | 19 | nr | 2.2 | No | No | Blood | Yes | a, b, e, h, j, n | a, d | 5 |
Das et al. | 2017 | USA | 2216 | 67.11 | 51 | 80.1 | 5.0 | Yes | No | Finger | Yes* | a, b, c, d, e, f, g, n, o | none | 6 |
Stewart et al. | 2009 | USA | 263 | 61 | 52 | 86.7 | 6.3 | Yes | No | Blood | Yes | a, b, c, d, e, f, g, h, i, j, k, l, m, n, s | a, b | 6 |
Kern et al. | 2014 | Sweden | 86 | 72.5 | 100 | nr | 16.5 | No | Yes | CSF | No CRP | a, e, h | a | 4 |
Zalli et al. | 2016 | Holland | 656 | 73 | 60 | nr | 5.0 | Yes | No | Blood | No | a, b, e, f, h, n, q | b, d | 6 |
Simanek et al. | 2019 | USA | 771 | 69.4 | 55 | nr | 1.5 | No | No | Blood2 | No | a, b, c, d, e, g, h, i, o | b, c | 6 |
Matthews et al. | 2010 | USA | 1714 | 46.2 | 100 | 51 | 1.0 | Yes | No | Blood | Yes | a, c, d, e, f, g, h, j, n, o, s | a, b, d | 6 |
Baune et al. | 2012 | Australia | 722 | 78.8 | 55 | nr | 2.0 | Yes | No | Blood | No | a, b, d, e, h, n, o, q, s | a, c | 5 |
Duivis et al. | 2015 | Holland | 1166 | 11.1 | 54 | nr | 3.0 | Yes | No | Blood | No* | a, b, d, e, h, j | d | 6 |
Jonker et al. | 2017 | Holland | 1084 | 16.2 | 54 | nr | 2.7 | Yes | Yes | Blood | Yes | , b, c, d, e, h, i, s | c, d | 6 |
Casaletto et al. | 2018 | USA | 165 | 72.6 | 49 | nr | 1.9 | Yes | No | Blood | No* | a, b, d, s | c, d | 4 |
Kim et al. | 2018 | Korea | 610 | 72.8 | 59 | nr | 2.4 | Yes | Yes | Blood | No CRP | , b, f, g, j, n, s | c | 5 |
Luciano et al. | 2012 | Scotland | 456 | 69.5 | 50 | nr | 3.0 | Yes | No | Blood | No* | a, b, e, j, o | a | 6 |
Luukinen et al. | 2010 | Finland | 404 | nr | 61 | nr | 2.5 | No | No | Blood | Yes | c, d | 5 | |
Matsushima et al. | 2015 | Japan | 64 | 72.05 | 74 | nr | 3.0 | Yes | No | Blood | No | b, c | 3 | |
Nelson et al. | 2018 | Australia | 63 | 14.84 | 41 | 77.8 | 0.6 | Yes | No | Saliva | No | a, b, e, h, q, s | b, c | 3 |
Niles et al. | 2018 | USA | 13375 | 67.79 | 60 | 81.61 | 4.0 | Yes | No | Finger | Yes | a, d, e, f, g, h, i, j, n, s | d | 5 |
Pasco et al. | 2010 | Australia | 644 | 47 | 100 | nr | 10.0 | No | Yes | Blood | No | a, e, h, j, n, o | none | 6 |
Tully et al. | 2015 | Australia | 1167 | 54.13 | 0 | nr | 4.9 | Yes | No | Blood | No | a, e, h, j, n | a, b, c | 5 |
Walss-Bass et al. | 2018 | USA | 195 | 13.37 | 54 | 58 | 0.9 | No | No | Blood | No* | , | c, d | 3 |
Oddy et al. | 2018 | Australia | 843 | 14 | 51 | 88 | 3.0 | Yes | No | Blood | Yes | a, c, d, e, h, i, j, s | d | 5 |
Jones et al. | 2017 | USA | 7477 | 63.47 | 100 | 53.8 | 15.4 | Yes | No | Blood | No* | a, c, d, e, f, g, h, i, j, o, s | d | 5 |
Chiang et al. | 2019 | USA | 187 | 16.4 | 57 | nr | 2.0 | Yes | No | Finger | Yes | a, b, d, e, h, i, n, o | d | 5 |
van den Biggelaar et al. | 2007 | Holland | 267 | 85 | 63 | nr | 1.0 | Yes | No | Blood | No | e, f, h, n, q, s | b, c | 6 |
Glaus et al. | 2018 | Switzerland | 2580 | 43.94 | 61 | 96.39 | 5.8 | No | Yes | Blood | Yes | a, b, c, d, e, h, j, n, o, s | d | 7 |
Caserta et al. | 2011 | USA | 141 | 9.31 | 46 | 47 | 0.5 | No | No | Blood | No CRP | a, b, d, e, s | a | 3 |
Mac Giollabhui et al. | 2019 | USA | 288 | 16.34 | 51 | 41 | 1.2 | Yes | No | Blood | Yes | e, f, g, q, s | a, c, d | 6 |
Forti et al. | 2010 | Italy | 652 | 74.54 | 55 | nr | 3.9 | Yes | No | Blood | No | a, b, d, e, n, o, q, s | c | 5 |
= If more than two follow-up points of unequal length were included in the study, the average was calculated for the purpose of meta-regression.
= Were CRP values greater than or equal to 10mg/L excluded. Where alternative cut-offs were used they are highlighted with “*” and marked “Yes” if they use a more conservative cut-off and “No” if they use a more liberal cut-off.
= Represents a selection of the most important and common exclusion criteria used across studies.
= Median age reported.
= 32.4% assessed via venipuncture.
nr = not reported; Finger = Blood drawn via finger prick; CSF = cerebrospinal fluid;
Covariates: a = age, b = sex, c = race, d = socio-economic status, e = index of body mass/body fat, f = baseline depression, g = baseline inflammatory biomarker, h = smoking status, i = alcohol use, j = physical activity, k = triglycerides, l = cholesterol, m = glucose, n = medical diagnosis, o = medication use, p = stress, q = cognitive functioning, r = other
Exclusion criteria (non-exhaustive list): a = medical diagnosis, b = medication use, c = psychiatric diagnosis, d = acute infection.